Form D · Biotechnology
Q Labs Holdings, Inc.
Cincinnati, OH · CIK 0001695181
Offering snapshot reported Jan 19, 2017 · SEC filing
- Reported sold
- $5.2M Offering amount: $5.2M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $74K Reported outside-investor minimum
- First sale
- Jan 4, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 19, 2017 | Initial | $5,200,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-278765
Source: Form D, filed Jan 19, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David G. Goins | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1400 Harrison Avenue
Cincinnati, OH, 45214
Cincinnati, OH, 45214